CNS Inflammatory Demyelination Disease

MichaelAbsoud.jpg

Lead investigator 

Dr Michael Absoud
Paediatric Neurology Department
Birmingham Children's Hospital 
Birmingham
B4 6NH

Email: Dr Michael Absoud

Overview

  • Inflammatory demyelinating diseases are a rare group of illnesses which affect the central nervous system (which is made up of the brain and spinal cord).
  • Many children recover well from these conditions, however, some have longer-term problems and may even have another bout of illness.
  • We currently do not know how often these conditions occur in children in the UK and Ireland, and we can’t always say what the future holds for a child who is affected. Along with other studies by our paediatric demyelination research group , our population study attempts to fill some of these gaps in our knowledge.

This study aims to:

  1. Find out how many children are affected by a new demyelinating event (incidence) in the UK and Ireland.
  2. Find out what happens to these children in the longer-term, for example how many children have a disability or a second episode.
  3. Describe treatments currently being used in the UK and Ireland.

Duration: September 2009 – September 2010     

Funding: Multiple Sclerosis Society and Action Medical Research Charities

Ethical approval: The study has Black Country Research Ethics Committee (09/H1202/92) and NIGB Ethics and Confidentiality Committee approvals (ECC/BPSU 4-03 [FT1] /2009).

Further Information                  

Support Group MS Society

Associated Publications, Resources and Links

  • Epilepsy12 FAQs
    Project Background What are the aims of the audit? Which services in the UK are eligible to ...
  • Epilepsy12 National Audit
    This national three-year audit, funded by the Health Quality Improvement Partnership (HQIP), aims to help improve ...
  • Stakeholder organisations
    The following organisations have registered as project stakeholders or are partners in the National Epilepsy Audit: ...
  • Methodology and data collection
    Project Methodology The Epilepsy12 national audit comprises three components: service descriptor, clinical audit ...
  • Mapping services
    We are currently mapping the UK in order to provide a pragmatic network of tertiary and secondary level services. We ...
  • Epilepsy12 - background and purpose
    Epilepsies are the commonest disabling chronic neurological disorders of childhood with a prevalence of approximately ...